INCLUSION FORMATION BY ATAXINS -1, -2, -3, AND -7

REFERENCES

• Becher M. W., Kotzuk J. A., Sharp A. H., Davies S. W., Bates G. P., Price D. L., Ross C. A. Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length. Neurobiology of Disease 1998; 4(6)387–397
   PubMed Web of Science ®Google Scholar
• Berke S. J., Schmied F. A., Brunt E. R., Ellerby L. M., Paulson H. L. Caspase-mediated proteolysis of the polyglutamine disease protein ataxin-3. Journal of Neurochemistry 2004; 89(4)908–918
   PubMedGoogle Scholar
• Busch A., Engemann S., Lurz R., Okazawa H., Lehrach H., Wanker E. E. Mutant huntingtin promotes the fibrillogenesis of wild-type huntingtin: A potential mechanism for loss of huntingtin function in Huntington's disease. Journal of Biological Chemistry 2003; 278(42)41452–41461
   PubMedGoogle Scholar
• Cancel G., Duyckaerts C., Holmberg M., Zander C., Yvert G., Lebre A. S., Ruberg M., Faucheux B., Agid Y., Hirsch E., Brice A. Distribution of ataxin-7 in normal human brain and retina. Brain 2000; 123(Part 12)2519–2530
   PubMedGoogle Scholar
• Chai Y., Shao J., Miller V. M., Williams A., Paulson H. L. Live-cell imaging reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a sequestration model of pathogenesis. Proceedings of the National Academy of Sciences of the United States of America 2002; 99(14)9310–9315
   PubMedGoogle Scholar
• Chai Y. H., Wu L. Z., Griffin J. D., Paulson H. L. The role of protein composition in specifying nuclear inclusion formation in polyglutamine disease. Journal of Biological Chemistry 2001; 276(48)44889–44897
   PubMedGoogle Scholar
• Chan H. Y. E., Warrick J. M., Gray-Board G. L., Paulson H. L., Bonini N. M. Mechanisms of chaperone suppression of polyglutamine disease: Selectivity, synergy and medullation of protein solubility in Drosophila. Human Molecular Genetics 2000; 9(19)2811–2820
   PubMed Web of Science ®Google Scholar
• Chen S., Berthelier V., Yang W., Wetzel R. Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity. Journal of Molecular Biology 2001; 311(1)173–182
   PubMedGoogle Scholar
• Chen S., Peng G. H., Wang X., Smith A. C., Grote S. K., Sopher B. L., La Spada A. R. Interference of Crx-dependent transcription by ataxin-7 involves interaction between the glutamine regions and requires the ataxin-7 carboxy-terminal region for nuclear localization. Human Molecular Genetics 2004; 13(1)53–67
   PubMedGoogle Scholar
• Cummings C. J., Reinstein E., Sun Y., Antalffy B., Jiang Y., Ciechanover A., Orr H. T., Beaudet A. L., Zoghbi H. Y. Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice. Neuron 1999; 24(4)879–892
   PubMed Web of Science ®Google Scholar
• DiFiglia M., Sapp E., Chase K. O., Davies S. W., Bates G. P., Vonsattel J. P., Aronin N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 1997; 277(5334)1990–1993
   PubMed Web of Science ®Google Scholar
• Duyckaerts C., Durr A., Cancel G., Brice A. Nuclear inclusions in spinocerebellar ataxia type 1. Acta Neuropathologia 1999; 97: 201–207
   PubMedGoogle Scholar
• Fujigasaki H., Martin J. J., De Deyn P. P., Camuzat A., Deffond D., Stevanin G., Dermaut B., Van Broeckhoven C., Durr A., Brice A. CAG repeat expansion in the TATA box-binding protein gene causes autosomal dominant cerebellar ataxia. Brain 2001; 124(Part 10)1939–1947
   PubMedGoogle Scholar
• Fujigasaki H., Uchihara T., Koyano S., Iwabuchi K., Yagishita S., Makifuchi T., Nakamura A., Ishida K., Toru S., Hirai S., Ishikawa K., Tanabe T., Mizusawa H. Ataxin-3 is translocated into the nucleus for the formation of intranuclear inclusions in normal and Machado-Joseph disease brains. Experimental Neurology 2000; 165(2)248–256
   PubMed Web of Science ®Google Scholar
• Gafni J., Hermel E., Young J. E., Wellington C. L., Hayden M. R., Ellerby L. M. Inhibition of calpain cleavage of huntingtin reduces toxicity: Accumulation of calpain/caspase fragments in the nucleus. Journal of Biological Chemistry 2004; 279(19)20211–20220
   PubMed Web of Science ®Google Scholar
• Garden G. A., Libby R. T., Fu Y. H., Kinoshita Y., Huang J., Possin D. E., Smith A. C., Martinez R. A., Fine G. C., Grote S. K., Ware C. B., Einum D. D., Morrison R. S., Ptacek L. J., Sopher B. L., La Spada A. R. Polyglutamine-expanded ataxin-7 promotes non-cell-autonomous purkinje cell degeneration and displays proteolytic cleavage in ataxic transgenic mice. Journal of Neuroscience 2002; 22(12)4897–4905
   PubMedGoogle Scholar
• Holmberg M., Duyckaerts C., Durr A., Cancel G., Gourfinkelan I., Damier P., Faucheux B., Trottier Y., Hirsch E. C., Agid Y., Brice A. Spinocerebellar ataxia type 7 (SCA7)—a neurodegenerative disorder with neuronal intranuclear inclusions. Human Molecular Genetics 1998; 7(5)913–918
   PubMed Web of Science ®Google Scholar
• Huynh D. P., Del Bigio M. R., Ho D. H., Pulst S. M. Expression of ataxin-2 in brains from normal individuals and patients with Alzheimer's disease and spinocerebellar ataxia 2. Annals of Neurology 1999; 45(2)232–241
   PubMed Web of Science ®Google Scholar
• Huynh D. P., Figueroa K., Hoang N., Pulst S. M. Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human. Nature Genetics 2000; 26(1)44–50
   PubMedGoogle Scholar
• Ikeda H., Yamaguchi M., Sugai S., Aze Y., Narumiya S., Kakizuka A. Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo. Nature Genetics 1996; 13(2)196–202
   PubMedGoogle Scholar
• Ishikawa K., Owada K., Ishida K., Fujigasaki H., Shun Li M., Tsunemi T., Ohkoshi N., Toru S., Mizutani T., Hayashi M., Arai N., Hasegawa K., Kawanami T., Kato T., Makifuchi T., Shoji S., Tanabe T., Mizusawa H. Cytoplasmic and nuclear polyglutamine aggregates in SCA6 Purkinje cells. Neurology 2001; 56(12)1753–1756
   PubMedGoogle Scholar
• Klein W. L. ADDLs & protofibrils—the missing links?. Neurobiology of Aging 2002; 23(2)231–235
   PubMedGoogle Scholar
• Klement I. A., Skinner P. J., Kaytor M. D., Yi H., Hersch S. M., Clark H. B., Orr H. T. Ataxin-1 nuclear localization and aggregation: Role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 1998; 95: 41–53
   PubMed Web of Science ®Google Scholar
• Klockgether T. Clinical approach to ataxic patients. Handbook of Ataxia Disorders, T. Klockgether. Marcel Dekker, New York 2000; 101–114
   Google Scholar
• Koyano S., Iwabuchi K., Yagishita S., Kuroiwa Y., Uchihara T. Paradoxical absence of nuclear inclusion in cerebellar Purkinje cells of hereditary ataxias linked to CAG expansion. Journal of Neurology Neurosurgery and Psychiatry 2002; 73(4)450–452
   PubMedGoogle Scholar
• Koyano S., Uchihara T., Fujigasaki H., Nakamura A., Yagishita S., Iwabuchi K. Neuronal intranuclear inclusions in spinocerebellar ataxia type 2: Triple-labeling immunofluorescent study. Neuroscience Letters 1999; 273(2)117–120
   PubMedGoogle Scholar
• Kuemmerle S., Gutekunst C. A., Klein A. M., Li X. J., Li S. H., Beal M. F., Hersch S. M., Ferrante R. J. Huntington aggregates may not predict neuronal death in Huntington's disease. Annals of Neurology 1999; 46(6)842–849
   PubMedGoogle Scholar
• Leavitt B. R., Guttman J. A., Hodgson J. G., Kimel G. H., Singaraja R., Vogl A. W., Hayden M. R. Wild-type huntingtin reduces the cellular toxicity of mutant huntingtin in vivo. American Journal of Human Genetics 2001; 68(2)313–324
   PubMed Web of Science ®Google Scholar
• Li F., Macfarlan T., Pittman R. N., Chakravarti D. Ataxin-3 is a histone-binding protein with two independent transcriptional corepressor activities. Journal of Biological Chemistry 2002; 277(47)45004–45012
   PubMedGoogle Scholar
• Li M., Miwa S., Kobayashi Y., Merry D. E., Yamamoto M., Tanaka F., Doyu M., Hashizume Y., Fischbeck K. H., Sobue G. Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy. Annals of Neurology 1998; 44(2)249–254
   PubMed Web of Science ®Google Scholar
• Menalled L. B., Sison J. D., Wu Y., Olivieri M., Li X. J., Li H., Zeitlin S., Chesselet M. F. Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington's disease knock-in mice. Journal of Neuroscience 2002; 22(18)8266–8276
   PubMedGoogle Scholar
• Nakamura K., Jeong S. Y., Uchihara T., Anno M., Nagashima K., Nagashima T., Ikeda S., Tsuji S., Kanazawa I. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Human Molecular Genetics 2001; 10(14)1441–1448
   PubMed Web of Science ®Google Scholar
• Pang J. T., Giunti P., Chamberlain S., An S. F., Vitaliani R., Scaravilli T., Martinian L., Wood N. W., Scaravilli F., Ansorge O. Neuronal intranuclear inclusions in SCA2: A genetic, morphological and immunohistochemical study of two cases. Brain 2002; 125(Part 3)656–663
   PubMedGoogle Scholar
• Paulson H. L., Perez M. K., Trottier Y., Trojanowski J. Q., Subramony S. H., Das S. S., Vig P., Mandel J. L., Fischbeck K. H., Pittman R. N. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 1997; 19(2)333–344
   PubMed Web of Science ®Google Scholar
• Perez M. K., Paulson H. L., Pittman R. N. Ataxin-3 with an altered conformation that exposes the polyglutamine domain is associated with the nuclear matrix. Human Molecular Genetics 1999; 8(13)2377–2385
   PubMed Web of Science ®Google Scholar
• Rubinsztein D. C., Wyttenbach A., Rankin J. Intracellular inclusions, pathological markers in diseases caused by expanded polyglutamine tracts??. Journal of Medical Genetics 1999; 36(4)265–270
   PubMedGoogle Scholar
• Sanchez I., Mahlke C., Yuan J. Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders. Nature 2003; 421(6921)373–379
   PubMed Web of Science ®Google Scholar
• Schmidt T., Landwehrmeyer G. B., Schmitt I., Trottier Y., Auburger G., Laccone F., Klockgether T., Volpel M., Epplen J. T., Schols L., Riess O. An isoform of ataxin-3 accumulates in the nucleus of neuronal cells in affected brain regions of SCA3 patients. Brain Pathology 1998; 8(4)669–679
   PubMed Web of Science ®Google Scholar
• Schols L., Bauer P., Schmidt T., Schulte T., Riess O. Autosomal dominant cerebellar ataxias: Clinical features, genetics, and pathogenesis. Lancet Neurology 2004; 3(5)291–304
   PubMed Web of Science ®Google Scholar
• Sieradzan K. A., Mechan A. O., Jones L., Wanker E. E., Nukina N., Mann D. Mx˙ A. Huntington's disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein. Experimental Neurology 1999; 156(1)92–99
   PubMedGoogle Scholar
• Skinner P. J., Koshy B. T., Cummings C. J., Klement I. A., Helin K., Servadio A., Zoghbi H. Y., Orr H. T. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature 1997; 389(6654)971–974
   PubMed Web of Science ®Google Scholar
• Slow E. J., Graham R. K., Osmand A. P., Devon R. S., Lu G., Deng Y., Pearson J., Vaid K., Bissada N., Wetzel R., Leavitt B. R., Hayden M. R. Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions. Proceedings of the National Academy of Sciences of the United States of America 2005; 102(32)11402–11407
   PubMedGoogle Scholar
• Tait D., Riccio M., Sittler A., Scherzinger E., Santi S., Ognibene A., Maraldi N. M., Lehrach H., Wanker E. E. Ataxin-3 is transported into the nucleus and associates with the nuclear matrix. Human Molecular Genetics 1998; 7(6)991–997
   PubMed Web of Science ®Google Scholar
• Tarlac V., Storey E. Role of proteolysis in polyglutamine disorders. Journal of Neuroscience Research 2003; 74(3)406–416
   PubMedGoogle Scholar
• Turnbull V. J., Storey E., Tarlac V., Walsh R., Stefani D., Clark R., Kelly L. Different ataxin-2 antibodies display different immunoreactive profiles. Brain Research 2004; 1027(1–2)103–116
   PubMedGoogle Scholar
• Uchihara T., Fujigasaki H., Koyano S., Nakamura A., Yagishita S., Iwabuchi K. Non-expanded polyglutamine proteins in intranuclear inclusions of hereditary ataxias—triple-labeling immunofluorescence study. Neuronal intranuclear inclusions in spinocerebellar ataxia type 2. Acta Neuropathologica (Berlin) 2001; 102(2)149–152
   PubMed Web of Science ®Google Scholar
• Walsh R., Storey E., Stefani D., Kelly L., Turnbull V. The roles of proteolysis and nuclear localisation in the toxicity of the polyglutamine diseases. Neurotoxicity Research 2005; 7(1–2)43–57
   PubMedGoogle Scholar
• Wanker E. E. Protein aggregation and pathogenesis of Huntington's disease: Mechanisms and correlations. Biological Chemistry 2000; 381(9–10)937–942
   PubMed Web of Science ®Google Scholar
• Warrick J. M., Chan H. Y. E., Gray-Board G. L., Chai Y. H., Paulson H. L., Bonini N. M. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nature Genetics 1999; 23(4)425–428
   PubMed Web of Science ®Google Scholar
• Watase K., Weeber E. J., Xu B., Antalffy B., Yuva-Paylor L., Hashimoto K., Kano M., Atkinson R., Sun Y., Armstrong D. L., Sweatt J. D., Orr H. T., Paylor R., Zoghbi H. Y. A long CAG repeat in the mouse Sca1 locus replicates SCA1 features and reveals the impact of protein solubility on selective neurodegeneration. Neuron 2002; 34(6)905–919
   PubMedGoogle Scholar
• Wellington C. L., Ellerby L. M., Leavitt B. R., Roy S., Nicholson D. W., Hayden M. R. Huntingtin proteolysis in Huntington disease. Clinical Neuroscience Research 2003; 3(3)129–139
   Web of Science ®Google Scholar
• Yoo S. Y., Pennesi M. E., Weeber E. J., Xu B., Atkinson R., Chen S., Armstrong D. L., Wu S. M., Sweatt J. D., Zoghbi H. Y. SCA7 knockin mice model human SCA7 and reveal gradual accumulation of mutant ataxin-7 in neurons and abnormalities in short-term plasticity. Neuron 2003; 37(3)383–401
   PubMed Web of Science ®Google Scholar
• Yvert G., Lindenberg K. S., Devys D., Helmlinger D., Landwehrmeyer G. B., Mandel J. L. SCA7 mouse models show selective stabilization of mutant ataxin-7 and similar cellular responses in different neuronal cell types. Human Molecular Genetics 2001; 10(16)1679–1692
   PubMedGoogle Scholar
• Zander C., Takahashi J., El Hachimi K. H., Fujigasaki H., Albanese V., Lebre A. S., Stevanin G., Duyckaerts C., Brice A. Similarities between spinocerebellar ataxia type 7 (SCA7) cell models and human brain: Proteins recruited in inclusions and activation of caspase-3. Human Molecular Genetics 2001; 10(22)2569–2579
   PubMedGoogle Scholar
• Zhang Y., Li M., Drozda M., Chen M., Ren S., Mejia Sanchez R. O., Leavitt B. R., Cattaneo E., Ferrante R. J., Hayden M. R., Friedlander R. M. Depletion of wild-type huntingtin in mouse models of neurologic diseases. Journal of Neurochemistry 2003; 87(1)101–106
   PubMedGoogle Scholar